Tim Barnett

Tim Barnett has a diverse work experience in the field of research and academia. Tim began their career at Emory University in 2000, where they worked as a Senior Research Associate. During their time there, they identified upregulated genes and studied mRNA stability and transcription initiation in Streptococcus pyogenes. Tim also discovered and characterized genes encoding sortase enzymes in the same organism.

In 2007, Tim joined Children's Healthcare of Atlanta as a Clinical Scientist. Here, they developed a rapid quantification system for measuring the susceptibility of cytomegalovirus to antiviral drugs. Tim also invented a technique to expose virus-infected cells to in vivo concentrations of antiviral drugs.

Moving forward, Tim joined the University of Queensland in 2010 as a Senior Research Fellow. Tim held this position until 2017, during which they contributed to various research projects.

In 2017, Tim started working at the Telethon Kids Institute as a Senior Research Fellow, where they continue to contribute to research initiatives.

Most recently, in 2022, Tim joined The University of Western Australia as a Senior Lecturer.

Overall, Tim Barnett's work experience showcases their expertise in research, particularly in the fields of molecular biology and infectious diseases.

Tim Barnett completed their Bachelor of Science (B.Sc.) degree in Microbiology, Biochemistry, Immunology, and Molecular Biology from The University of Western Australia, studying from 1991 to 1995. Tim then pursued a Doctor of Philosophy (PhD) in Microbiology, General at the University of Tasmania from 1995 to 2000.